Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
2.
Int Immunopharmacol ; 88: 106791, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32871480

RESUMO

Delvestidine (DLTD) is a monomeric compound isolated from Aconitum leucostomum Worosch, a widely used medicine for local treatment of rheumatoid arthritis (RA). Studies have shown that Aconitum leucostomum Worosch. can inhibit maturation of bone marrow-derived dendritic cells (BMDCs). Further, microRNAs (miRNAs) have regulatory effects on DC maturity and function. However, the mechanism underlying DLTD effects on DC maturity and RA remains to be elucidated. This study investigated whether DLTD-mediated inhibition of DC maturation is regulated by miRNAs. LPS-induced mature BMDCs were treated with DLTD for 48 h. CD80 and CD86 expression on BMDCs was detected by flow cytometry, and levels of inflammatory factors IL-6, IL-23, IL-1ß, and TNF-α were detected by ELISA and PCR. Further, gene expression and miRNA expression profiles were investigated by bioinformatics analysis and verified by PCR. DLTD was found to inhibit CD80 and CD86 expression on the surface of BMDCs and secretion of inflammatory factors IL-6, IL-23, IL-1ß, and TNF-α. In total, 54 differentially expressed miRNAs were detected, including 29 up-regulated and 25 down-regulated miRNAs after DLTD treatment. Analysis of biological information revealed that the differentially expressed target genes mainly regulated biological processes, including cell differentiation, cell cycle, and protein kinase complexes. Additionally, miR-511-3p downstream targets Calcr, Fzd10, and Eps8, were closely related to BMDCs maturation. DLTD may induce BMDCs maturity through regulation of miRNAs that affect Calcr, Fzd10, and Eps8 gene signals.


Assuntos
Aconitum/química , Células da Medula Óssea/imunologia , Células da Medula Óssea/metabolismo , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , MicroRNAs/imunologia , MicroRNAs/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/efeitos dos fármacos , Proteínas Adaptadoras de Transdução de Sinal/genética , Animais , Antígeno B7-1/efeitos dos fármacos , Antígeno B7-1/metabolismo , Antígeno B7-2/efeitos dos fármacos , Antígeno B7-2/metabolismo , Proteína Semelhante a Receptor de Calcitonina/efeitos dos fármacos , Proteína Semelhante a Receptor de Calcitonina/genética , Diferenciação Celular , Células Cultivadas , Biologia Computacional , Citocinas/genética , Citocinas/metabolismo , Receptores Frizzled/efeitos dos fármacos , Receptores Frizzled/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Lipopolissacarídeos/toxicidade , Camundongos Endogâmicos BALB C , MicroRNAs/genética , Antígenos de Histocompatibilidade Menor/efeitos dos fármacos , Antígenos de Histocompatibilidade Menor/genética , Receptores de Citocinas/efeitos dos fármacos , Receptores de Citocinas/genética
3.
FEBS Lett ; 591(1): 118-128, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27883176

RESUMO

Dysregulation of microRNAs (miRNAs) can contribute to tumorigenesis in cancers. In this study, we found that miR-429 was downregulated in cervical cancer (CC) tissues and suppressed cell viability and proliferation while promoting apoptosis in CC cells. IKKß was a novel target gene of miR-429 and ectopic expression of IKKß abrogated the phenotypes induced by miR-429. When IKKß was downregulated by miR-429, nuclear factor κB (NF-κB) pathway activation, interleukin-6 (IL-6), and interferon-ß (IFN-ß) production were decreased in CC cells. These findings indicate that miR-429 is involved in regulation of the NF-κB pathway by targeting IKKß and functions as a tumor suppressor in cervical carcinogenesis.


Assuntos
Carcinogênese/patologia , Quinase I-kappa B/metabolismo , MicroRNAs/metabolismo , NF-kappa B/metabolismo , Neoplasias do Colo do Útero/genética , Apoptose/genética , Sequência de Bases , Carcinogênese/genética , Linhagem Celular Tumoral , Proliferação de Células , Sobrevivência Celular , Regulação para Baixo/genética , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Interferon beta/metabolismo , Interleucina-6/metabolismo , MicroRNAs/genética , Neoplasias do Colo do Útero/patologia
4.
Br J Cancer ; 115(6): 731-40, 2016 09 06.
Artigo em Inglês | MEDLINE | ID: mdl-27537390

RESUMO

BACKGROUND: Dysregulation of microRNAs (miRNAs) has been found in human epithelial ovarian cancer (EOC). However, the role and mechanism of action of miR-23a in EOC remain unclear. METHODS: The roles of miR-23a, IKKα, and ST7L in EOC were determined by MTT, colony formation, wounding healing, transwell, flow cytometry, immunofluorescence, RT-qPCR, and western blotting experiments. miR-23a target genes were validated by EGFP reporter assays, RT-qPCR, and western blotting analysis. RESULTS: miR-23a is upregulated and promotes tumorigenic activity by facilitating the progress of cell cycle and EMT and repressing apoptosis in EOC cells. miR-23a enhances the expression of IKKα but suppresses the expression of ST7L by binding the 3'UTR of each transcript in EOC cells. The proliferation, migration, and invasion of EOC cells are increased by IKKα and inhibited by ST7L. Furthermore, miR-23a activates NF-κB by upregulating IKKα and WNT/MAPK pathway by downregulating ST7L. CONCLUSIONS: miR-23a functions as an oncogene by targeting IKKα and ST7L, thus contributing to the malignancy of EOC cells.


Assuntos
Carcinoma/genética , Regulação Neoplásica da Expressão Gênica , Quinase I-kappa B/fisiologia , MicroRNAs/genética , Proteínas de Neoplasias/fisiologia , Neoplasias Ovarianas/genética , RNA Neoplásico/genética , Proteínas de Ligação a RNA/fisiologia , Regiões 3' não Traduzidas/genética , Carcinoma/patologia , Divisão Celular , Linhagem Celular Tumoral , Movimento Celular , Feminino , Genes Reporter , Vetores Genéticos , Humanos , Quinase I-kappa B/biossíntese , Quinase I-kappa B/genética , Sistema de Sinalização das MAP Quinases/genética , NF-kappa B/metabolismo , Invasividade Neoplásica , Proteínas de Neoplasias/biossíntese , Proteínas de Neoplasias/genética , Neoplasias Ovarianas/patologia , Proteínas de Ligação a RNA/biossíntese , Proteínas de Ligação a RNA/genética , Proteínas Supressoras de Tumor , Via de Sinalização Wnt/genética
5.
J Virol Methods ; 222: 164-9, 2015 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-26141732

RESUMO

An immunochromatographic strip (ICS) was developed for the detection of swine antibodies against glycoprotein E (gE) in Pseudorabies Virus (PRV). In this test, Staphylococcal Protein A (SPA) labeled with colloidal gold was dispensed on a conjugate pad as the detector. Purified PRV-gE and pig-IgG were blotted on a nitrocellulose membrane for the test (T) and control lines (C), respectively. If the tested serum contains IgG antibodies against PRV-gE, the IgG will interact with the colloidal gold-SPA to form a complex (gold-SPA-swine IgG). The complex will react with the immobilized PRV-gE on the T line and the Pig-IgG in the C line of the ICS to form two visible red bands. If there is no IgG antibody against PRV-gE in the sample serum, only the C line will be visible. The ICS was capable of specifically detecting PRV-gE antibody within 5 min, and its stability and reproducibility were quite good after storage at 4°C and use within 4 months. Using an IDEXX Pseudorabies Virus gE Antibody Test Kit (IDEXX PRV gE Ab test) as a reference, the relative specificity and sensitivity of the ICS were determined to be 81.6% and 90.7%, respectively. Furthermore, there was a good agreement between the results obtained by the commercial product and the ICS (kappa=0.7289).


Assuntos
Anticorpos Antivirais/sangue , Cromatografia de Afinidade/métodos , Herpesvirus Suídeo 1/imunologia , Pseudorraiva/diagnóstico , Animais , Sensibilidade e Especificidade , Suínos , Temperatura , Fatores de Tempo , Proteínas do Envelope Viral/imunologia
6.
J Biol Chem ; 289(35): 24724-35, 2014 Aug 29.
Artigo em Inglês | MEDLINE | ID: mdl-25049231

RESUMO

MicroRNAs (miRNAs) have been shown to play important roles in carcinogenesis. However, their underlying mechanisms of action in hepatocellular carcinoma (HCC) are poorly understood. Recent evidence suggests that epigenetic silencing of miRNAs through tumor suppression by CpG island hypermethylation may be a common hallmark of human tumors. Here, we demonstrated that miR-941 was significantly down-regulated in HCC tissues and cell lines and was generally hypermethylated in HCC. The overexpression of miR-941 suppressed in vitro cell proliferation, migration, and invasion and inhibited the metastasis of HCC cells in vivo. Furthermore, the histone demethylase KDM6B (lysine (K)-specific demethylase 6B) was identified as a direct target of miR-941 and was negatively regulated by miR-941. The ectopic expression of KDM6B abrogated the phenotypic changes induced by miR-941 in HCC cells. We demonstrated that miR-941 and KDM6B regulated the epithelial-mesenchymal transition process and affected cell migratory/invasive properties.


Assuntos
Carcinoma Hepatocelular/genética , Metilação de DNA , Histona Desmetilases com o Domínio Jumonji/genética , Neoplasias Hepáticas/genética , MicroRNAs/genética , Regiões 3' não Traduzidas , Sequência de Bases , Carcinoma Hepatocelular/enzimologia , Carcinoma Hepatocelular/patologia , Linhagem Celular Tumoral , Primers do DNA , Regulação para Baixo , Humanos , Neoplasias Hepáticas/enzimologia , Neoplasias Hepáticas/patologia , RNA Mensageiro/genética
7.
Cardiovasc Diabetol ; 12: 118, 2013 Aug 19.
Artigo em Inglês | MEDLINE | ID: mdl-23958390

RESUMO

BACKGROUND AND AIM: Limitations of the currently recommended stepwise treatment pathway for type 2 diabetes mellitus (T2DM), especially the failure of monotherapies to maintain good glycemic control, have prompted use of early, more aggressive combination therapies.The VISION study is designed to explore the efficacy and safety of vildagliptin as an add-on to metformin therapy compared with up-titration of metformin monotherapy in Chinese patients with T2DM. METHODS: VISION, a 24-week, phase 4, prospective, randomized, multicenter, open-label, parallel-group study, will include 3312 Chinese T2DM patients aged ≥18 years who are inadequately controlled (6.5% >HbA1c ≤9%) by metformin (750-1000 mg/day). Eligible patients will be randomized to receive either vildagliptin plus metformin or up-titration of metformin monotherapy (5:1). Patients will also be subgrouped (1:1:1:1) based on their age and body mass index (BMI): <60 years and <24 kg/m²; <60 years and ≥24 kg/m²; ≥60 years and <24 kg/m²; and ≥60 years and ≥24 kg/m². CONCLUSION: The VISION study will test the hypothesis that early use of combination therapy with vildagliptin and metformin will provide good glycemic control and will be better tolerated than up-titration of metformin monotherapy. The study will also correlate these benefits with age and BMI.


Assuntos
Adamantano/análogos & derivados , Diabetes Mellitus Tipo 2/tratamento farmacológico , Inibidores da Dipeptidil Peptidase IV/uso terapêutico , Hipoglicemiantes/uso terapêutico , Metformina/uso terapêutico , Nitrilas/uso terapêutico , Pirrolidinas/uso terapêutico , Projetos de Pesquisa , Adamantano/efeitos adversos , Adamantano/uso terapêutico , Fatores Etários , Povo Asiático , Biomarcadores/sangue , Índice de Massa Corporal , China/epidemiologia , Protocolos Clínicos , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/etnologia , Inibidores da Dipeptidil Peptidase IV/efeitos adversos , Quimioterapia Combinada , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Hipoglicemiantes/efeitos adversos , Masculino , Metformina/efeitos adversos , Pessoa de Meia-Idade , Nitrilas/efeitos adversos , Estudos Prospectivos , Pirrolidinas/efeitos adversos , Fatores de Tempo , Resultado do Tratamento , Vildagliptina
8.
Acta Oncol ; 49(1): 76-84, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-19878069

RESUMO

BACKGROUND: Breast carcinoma is one of most prevalent malignant tumors occurring in women. Short of prevention, detection of breast carcinoma at an early, still curable stage would offer the best route to decrease its mortality rates. This highlights the urgent need for suitable biomarkers for early diagnosis and a better understanding of the disease pathogenesis. MATERIAL AND METHODS: NMPs were extracted from normal human breast tissue (Group I), from hyperplastic mammary tissue specimens (Group II), from atypical epithelial hyperplasia specimens (Group III), and from breast carcinoma (Group IV) tissue. Differential proteome profiles were established and analyzed by means of immobilized pH gradient-based two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The different NMPs were analyzed in the National Center for Biotechnology Information (NCBI) database with Mascot software. RESULTS: Well-resolved, reproducible 2-DE profiles of human breast tissues were obtained. Average protein spots were 904 +/- 58, 912 +/- 51, 931 +/- 63, 944 +/- 70 in Group I, Group II, Group III, and Group IV, respectively. Several different proteins were analyzed using mass spectrometry and bioinformation. Of these, 12 were well characterized. Compared to Group I, three proteins were up-regulated in Groups II, III, and IV, including Hsp27, prohibitin, and laminA/C. Upregulation was confirmed using Western blotting and immunohistochemical analysis. The correlation of prohibitin expression with clinicopathological features was also investigated. DISCUSSION: The proteins identified in this study may potentially prove to be useful markers for breast carcinoma diagnosis.


Assuntos
Biomarcadores Tumorais/análise , Neoplasias da Mama/metabolismo , Proteínas Associadas à Matriz Nuclear/biossíntese , Lesões Pré-Cancerosas/metabolismo , Western Blotting , Neoplasias da Mama/genética , Eletroforese em Gel Bidimensional , Feminino , Expressão Gênica , Perfilação da Expressão Gênica , Humanos , Imuno-Histoquímica , Proteínas Associadas à Matriz Nuclear/genética , Lesões Pré-Cancerosas/genética , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Regulação para Cima
9.
Fish Physiol Biochem ; 36(3): 677-686, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19685219

RESUMO

A drug-drug interaction occurs when the effect of one drug is altered by the presence of another drug which is generally associated with the induction of cytochrome P450s (CYPs) activity. Thus, unexpected treatment failures often happen resulting from inappropriate coadministration in fisheries. However, little information is available about CYP induction in fish. The reaction of difloxacin (DIF) biotransformation to sarafloxacin (SAR) belongs to N-demethylation catalyzed mainly by CYP(s). In order to supply useful information on CYP induction, the present study assessed the effects of fish-specific CYP inducers on DIF N-demethylation and enzyme kinetics in kidney cell of Chinese idle (CIK; grass carp (Ctenopharyngodon idellus)) by RP-HPLC. Results demonstrated that the amounts of SAR formation and enzymatic parameters Clint and Vmax were significantly increased due to beta-naphthoflavone (BNF) pretreatment. Therefore, we suggest that CYP1A may be involved in DIF N-demethylation in CIK. This study provides instructive information to ensure treatment success via avoiding CYP induction in fisheries.


Assuntos
Ciprofloxacina/análogos & derivados , Cyprinidae/fisiologia , Citocromo P-450 CYP1A1/biossíntese , Interações Medicamentosas/fisiologia , Indução Enzimática/fisiologia , Análise de Variância , Animais , Biotransformação/fisiologia , Cromatografia Líquida de Alta Pressão , Ciprofloxacina/química , Ciprofloxacina/farmacocinética , Rim/citologia , Rim/metabolismo , Cinética , Estrutura Molecular , beta-Naftoflavona
10.
Mol Biol Rep ; 36(4): 807-12, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18427947

RESUMO

Breast carcinoma (BC) is a prevalent malignant tumour occurring in women. Many studies have indicated the role of human papilloma virus type 16 (HPV16) in the pathogenesis of BC; however, the correlations of HPV16 infection with the clinicopathologic features of BC and the expressions of c-erbB-2 and bcl-2 have not yet been elucidated. In this study, HPV16 was detected by amplifying the HPV16 E6 gene by the polymerase chain reaction method, and the expressions of c-erbB-2 and bcl-2 in 40 BCs and 20 normal breast tissue samples, obtained from Shaanxi Province, were examined using the streptavidin-peroxidase method with monoclonal antibodies specific to c-erbB-2 and bcl-2. The infection rate of HPV16 E6 and the positive expression rate of c-erbB-2 were significantly higher in the BCs than in the normal tissues (HPV16 E6: 60% vs. 5%; c-erbB-2: 42.5% vs. 5%, P < 0.05). However, the positive expression rate of bcl-2 was significantly lower in the BCs than in the normal tissues (67.5% vs. 95%, P < 0.05). The infection rate of HPV16 did not correlate with any of the pathological features observed (P > 0.05). HPV16 infection correlated with bcl-2 expression (P = 0.015) but not with c-erbB-2 expression (P = 0.747) in the BCs. Interestingly, HPV16 infection correlated with bcl-2 expression in grade I BCs (P = 0.018) but not in grade II-III BCs (P = 0.633). Our data suggest that HPV16 infection is correlated with bcl-2 expression in BCs.


Assuntos
Neoplasias da Mama/metabolismo , Neoplasias da Mama/virologia , Regulação Neoplásica da Expressão Gênica/genética , Papillomavirus Humano 16/fisiologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Receptor ErbB-2/metabolismo , Adulto , Idoso , Neoplasias da Mama/genética , Humanos , Pessoa de Meia-Idade , Proteínas Oncogênicas Virais/genética , Proteínas Proto-Oncogênicas c-bcl-2/genética , Receptor ErbB-2/genética , Proteínas Repressoras/genética
11.
J Rheumatol ; 35(2): 278-84, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18085734

RESUMO

OBJECTIVE: To identify the clinical characteristics, pathological changes, and outcome of patients with primary Sjögren's syndrome (pSS). METHODS: All patients with pSS and renal involvement who were admitted to Ruijin Hospital from April 1993 to December 2006 were included. All the data of clinical features and pathological changes were retrospectively analyzed. Forty-one patients underwent renal biopsies. RESULTS Our study included 130 patients with pSS: 122 women and 8 men. Ages ranged from 16 to 68 years (mean 44.1 +/- 11.52). Ninety-five patients (73.1%) developed renal tubular acidosis (RTA); 91 were found to have distal RTA. Nine patients presented with hypokalemic paralysis. Four patients developed Fanconi syndrome and 3 were proved to have nephrogenic diabetes insipidus. Twenty-seven of 130 patients (20.8%) developed tubular proteinuria and 18/130 (13.8%) presented glomerular involvement. Thirty-five patients (27.7%) developed renal failure (serum creatinine > 115 micromol/l). Most patients (70.8%) had increased serum IgG levels. The incidence of chronic interstitial nephritis was 80.5% among all the biopsy materials. Immunofluorescent staining was negative in most renal tissue. Ninety-six patients were treated with corticosteroids and/or immunosuppressant. Eighteen recovered renal function. CONCLUSION: Patients with pSS commonly present with renal impairment, mainly from renal tubular dysfunction. The combination of corticosteroids and immunosuppressors significantly improves the renal function of patients with pSS. There is a correlation between hypergammaglobulinemia and distal RTA. The renal acidification capacity for patients with hypergammaglobulinemia. should be monitored.


Assuntos
Acidose Tubular Renal/complicações , Acidose Tubular Renal/patologia , Túbulos Renais Distais/patologia , Síndrome de Sjogren/complicações , Acidose Tubular Renal/tratamento farmacológico , Adolescente , Corticosteroides/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Taxa de Filtração Glomerular , Humanos , Imunossupressores/uso terapêutico , Masculino , Pessoa de Meia-Idade , Nefrite/complicações , Nefrite/patologia
12.
J Rheumatol ; 34(12): 2451-6, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17985400

RESUMO

OBJECTIVE: To investigate the features, followup data, and outcomes of patients with propylthiouracil (PTU)-associated antineutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis. METHODS: Nineteen patients with PTU-associated ANCA-positive vasculitis diagnosed in our hospital from 2000 to 2006 were analyzed retrospectively. RESULTS: Our data showed a female predominance among the patients. Eleven patients had involvement of more than one organ. Renal involvement was the most common manifestation. Fourteen patients underwent renal biopsy. Four patients had focal proliferative glomerulonephritis with crescent formation. Two had necrotizing glomerulonephritis with crescent formation. Two patients had minor glomerular abnormalities, 2 had IgA nephropathy, one had membranous nephropathy, one had focal proliferative glomerulonephritis, one had granulomatous interstitial nephritis, and the remaining one had focal segmental glomerular sclerosis. Immune complex glomerulonephritis was found in 3 patients. On indirect immunofluorescence, 17 patients were perinuclear-pattern ANCA-positive, one was positive for atypical ANCA, and one was positive for cytoplasmic-pattern-ANCA. By ELISA, 4 patients were positive for both myeloperoxidase (MPO)-ANCA and proteinase-3 (PR3)-ANCA, one was positive for PR3-ANCA only, and the others were positive for MPO-ANCA only. For the treatment of vasculitis, 5 patients received prednisone alone, 10 received prednisone and cyclophosphamide, and the remaining 4 did not receive prednisone or cyclophosphamide. During followup, 15 patients achieved remission, 3 patients died, and one patient depended on dialysis. In general, MPO-ANCA concentration did not correlate with disease progression, and a delayed decrease of MPO-ANCA concentration was found in most patients who achieved remission. CONCLUSION: Most patients with PTU-associated ANCA-positive vasculitis had good outcomes; however, severe cases existed. We suggest early recognition and adequate treatment are necessary to improve outcome.


Assuntos
Anticorpos Anticitoplasma de Neutrófilos/sangue , Antimetabólitos/efeitos adversos , Propiltiouracila/efeitos adversos , Vasculite/induzido quimicamente , Vasculite/terapia , Adulto , Idoso , Anticorpos Anticitoplasma de Neutrófilos/imunologia , Feminino , Humanos , Nefropatias/sangue , Nefropatias/induzido quimicamente , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Vasculite/sangue , Vasculite/imunologia
13.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 21(4): 507-9, 2005 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-15989803

RESUMO

AIM: To study the relationship between the interleukin-6(IL-6) level in serum and broncheoalveolar lavage fluid(BALF) and non-small cell lung cancer(NSCLC). METHODS: The concentration of IL-6 in serum or BALF of 62 NSCLC patients, 36 patients of pulmonary inflammatory diseases (PID) and 25 normal controls were measured by ELISA. RESULTS: (1)The concentration of IL-6 in BALF of NSCLC patients was significantly higher than that of PID patients and normal controls (P<0.01). The concentration of IL-6 in sera of NSCLC patients was higher than that of normal controls (P<0.01) but not statistically different from that of PID patients. (2)In patients with NSCLC, the concentration of IL-6 in BALF was slightly higher than that of serum IL-6, but this difference was not statistically significant (P>0.05). (3)Serum IL-6 level was higher in NSCLC of advanced stages (stage IIIa, IIIb and IV), as compared with that in NSCLC patients of early stages (stage Ia-IIb). BALF IL-6 level of NSCLC patients at different stages was not different. (4)IL-6 (level in serum but not in BALF) of PID patients correlated with the serum concentration of C reactive protein (r=0.74). CONCLUSION: IL-6 in BALF might be used as a marker for NSCLC. Serum IL-6 level might be an indicator for the stage of NSCLC. The serum IL-6 can also reflect the severity of acute lung inflammatory response.


Assuntos
Líquido da Lavagem Broncoalveolar/química , Carcinoma Pulmonar de Células não Pequenas/sangue , Carcinoma Pulmonar de Células não Pequenas/metabolismo , Interleucina-6/análise , Interleucina-6/sangue , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/metabolismo , Reação de Fase Aguda/sangue , Reação de Fase Aguda/metabolismo , Reação de Fase Aguda/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/sangue , Biomarcadores Tumorais/metabolismo , Proteína C-Reativa , Carcinoma Pulmonar de Células não Pequenas/diagnóstico , Carcinoma Pulmonar de Células não Pequenas/patologia , Estudos de Casos e Controles , Feminino , Humanos , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/patologia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Pneumonia/sangue , Pneumonia/metabolismo , Pneumonia/patologia
14.
Chin Med J (Engl) ; 118(24): 2072-6, 2005 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-16438905

RESUMO

BACKGROUND: As one of the intercellular adhesion molecules, CD58 plays important roles in promotion of the adhesion between T cells and target cells, hyperplasia, activation of T cells and natural killer cells, and balance between Th1 and Th2. We studied the relationship between the levels of CD58 expression in peripheral blood mononuclear cells (PBMCs) and severity of HBV infection. METHODS: The levels of CD58 mRNA in PBMCs were detected using quantitative reverse transcription PCR. The percentage of CD58 positive cells was detected by flow cytometry in patients and healthy controls. RESULTS: The levels of CD58 mRNA and the percentage of CD58 positive cells in patients infected with HBV were significantly higher than that in the control. Based on severity of HBV infection, the patients were classified into four groups. The expression of CD58 increased significantly in an order from mild chronic, moderate chronic, severe chronic to severe hepatitis groups. The levels of CD58 mRNA and the percentage of CD58 positive cells in PBMCs from patients with HBV infection were both positively correlated with serum levels of ALT and AST. CONCLUSION: The level of CD58 expression is related with the severity of HBV infection and the degree of liver damage.


Assuntos
Antígenos CD58/genética , Hepatite B/sangue , Leucócitos Mononucleares/metabolismo , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Hepatite B/fisiopatologia , Humanos , RNA Mensageiro/análise
15.
Beijing Da Xue Xue Bao Yi Xue Ban ; 36(2): 181-4, 2004 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-15100739

RESUMO

OBJECTIVE: To construct sense and antisense eukaryotic expression vector of novel gene Collectrin and identify its function in cell growth. METHODS: The open reading frame of Collectrin was amplified by PCR and inserted into pcDNA3.1/V5-His plasmid. The recombinant plasmid was identified by restriction enzyme analysis and sequencing analysis. The recombinant plasmid was transfected into M-1 cell by using lipofectin mediation after being identified by restriction enzyme analysis and sequencing analysis. RT-PCR and Western blot were performed to identify the expression of Collectrin. Beta-Gal staining was used to define the effect of transfection. The growth of M-1 cells was examined by MTT and cell counting. RESULTS: Compared with control group, the expression of Collectrin was decreased significantly at both nucleotide and protein levels transfected by antisense vector, but elevated in sense group. The cell growth was blocked after being transfected by antisense plasmid. CONCLUSION: The sense and antisense eukaryotic expression vector of novel gene Collectrin was successfully constructed. Collectrin was one of basic factors in cell growth.


Assuntos
Glicoproteínas de Membrana/genética , Animais , Western Blotting , Divisão Celular , Glicoproteínas de Membrana/fisiologia , Camundongos , Plasmídeos , Reação em Cadeia da Polimerase , RNA Mensageiro/análise , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...